Biotech · Private company
Dong-A ST Co., Ltd.
Track this companyFree. Adds Dong-A ST Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- DMB-3115Phase 3 · Moderate to Severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- StelaraPhase 3 · Moderate to Severe Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- DA-9805 45mgPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DA-9805 90mgPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Motilitone 30mgPhase 2 · DyspepsiaClinicalTrials.gov · fetched Nov 12, 2026
- DA-1241Phase 1 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
- SitagliptinPhase 1 · Diabetes Mellitus, Type 2ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque PsoriasisPHASE3 · COMPLETED · started Apr 28, 2021ClinicalTrials.gov NCT04785326 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DMPHASE1 · COMPLETED · started Aug 29, 2018ClinicalTrials.gov NCT03646721 · fetched Nov 12, 2026
- Safety and Efficacy of DA-9805 for Parkinson's DiseasePHASE2 · COMPLETED · started Feb 6, 2018ClinicalTrials.gov NCT03189563 · fetched Nov 12, 2026
- Study of Motilitone to Treat Functional DyspepsiaPHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02365701 · fetched Nov 12, 2026
- Study of DA-9801 to Treat Diabetic NeuropathyPHASE2 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01822925 · fetched Nov 12, 2026